Tamiflu 75mg & 30mg - Award Notice
Award Notice Posted
A later notice was posted: the Limited / Sole Source Justification from .
- Solicitation number
- 75A50324F80002
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Awarded
- to Genentech Usa, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36F79723D0219-75A50324F80002 Federal contract award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice from the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response announces the award of a contract to Genentech USA for Tamiflu 75mg and 30mg capsules. The contract number is 36F79723D0219 and was awarded on November 17, 2023 for $396,995,520 to provide 396,995,520 capsules of Tamiflu 75mg and 30mg to the agency for stockpiling purposes.
Notice text
Tamiflu 75mg capsules (NDC 0004-0800-85) and Tamiflu 30mg capsules (NDC 0004-0802-85).
Awarded contract 36F79723D0219 to Genentech USA for 396999520.00 on 2023-11-17.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Tamiflu 75mg & 30mg - LSJ | Limited / Sole Source Justification | |
| This notice | Award Notice | |
| Limited Source Justification - Tamiflu 30mg & 75mg capsules | Limited / Sole Source Justification |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity